Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Camille Febvay"'
Autor:
Anne-Sophie Marty, Tristan Jurkiewicz, Romain Mouchel, Camille Febvay, Thierry Caillat, Carole Burillon
Publikováno v:
Eyecontact lens. 48(8)
To evaluate the utility of the SPOT scleral lens (Oxygen Permeable Scleral Lens of Thonon; LAO, Thonon-les-Bains, France) in the management of the irregular cornea after refractive surgery.We included 19 patients (35 eyes) with irregular corneas afte
Autor:
Anne-Pauline Bellanger, Louise Vuillemey, François Aubin, Anne-Sophie Gauthier, Bernard Delbosc, Eve Puzenat, Marc Puyraveau, Camille Febvay, Cécile Chagué
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36
Autor:
Arnaud Risler, Fabrice Pirot, Samira Filali, Damien Salmon, Christine Pivot, Annamaria Cucina, Camille Febvay, Michel Pélandakis
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2019, 556, pp.330-337. ⟨10.1016/j.ijpharm.2018.12.016⟩
International Journal of Pharmaceutics, Elsevier, 2019, 556, pp.330-337. ⟨10.1016/j.ijpharm.2018.12.016⟩
International audience; Poor bioavailability and low residence time limit the efficiency of conventional biguanide-based eye drops against Acanthamoeba keratitis. The aim of this work was to formulate an original anti-amoebic thermoreversible ocular
Autor:
Irène Gallais Sérézal, François Aubin, Cécile Chagué, Louise Vuillemey, Eve Puzenat, Bernard Delbosc, Anne-Sophie Gauthier, Camille Febvay
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A55-A56
Introduction Le dupilumab est la premiere biotherapie disponible pour la dermatite atopique (DA). Il repose sur l’inhibition de l’IL-4 et de l’IL-13. Cette therapie peut entrainer des conjonctivites, dont l’incidence est evaluee a 5–28 % se
Autor:
Christiane Broussolle, Camille Febvay, Carole Burillon, Pascal Sève, Jean Iwaz, Laurent Perard, Laurent Kodjikian, Delphine Maucort-Boulch, Yvan Jamilloux
Publikováno v:
British Journal of Ophthalmology
British Journal of Ophthalmology, BMJ Publishing Group, 2015, 99, pp.1372-6
British Journal of Ophthalmology, 2015, 99, pp.1372-6
British Journal of Ophthalmology, BMJ Publishing Group, 2015, 99, pp.1372-6
British Journal of Ophthalmology, 2015, 99, pp.1372-6
Aims To determine the clinical features of patients with uveitis with biopsy-proven sarcoidosis, document differences in these features according to ethnicity, age and sex, and assess the diagnostic value of biochemical and imaging examinations. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54d79419b3666fe10e11eeba2dd1b10
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02044752
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02044752